News

Glonhui May 11｜Citi issued a report stating that BeiGene's first-quarter results were strong, with total revenue 5% higher than the bank's estimate. Management raised full-year 2026 revenue guidance by $100 million to $6.3-6.5 billion, while operating expense guidance remains unchanged. Operating profit is therefore expected to increase by $50 million. The bank updated its model to reflect the latest performance guidance, raising BeiGene's US stock target price from $430 to $453, with a "Buy" rating.The report noted that BeiGene continues to advance its solid tumor projects, moving from early to later stages. Clinical proof-of-concept (PoC) data for CDK4i/B7-H4 ADC and GPC3x4-1BB are expected to be released at the ASCO Annual Meeting in 2026. In addition, apart from the BTK degrader, which is expected to submit an accelerated approval application for relapsed/refractory CLL in the second half of 2026, the bank looks forward to the fixed duration uMRD data from the ZS frontline Phase III CELESTIAL-301 trial, which is expected to be released this year.

BlockBeats News, on May 11, Minara AI officially launched the AI Prediction Copilot today, integrating the Hyperliquid HIP-4 prediction market into the Copilot trading assistance system, becoming the first AI-powered tool stack for prediction markets based on HIP-4. Leveraging AI to automatically analyze BTC short-term trends, support and resistance levels, odds value, and market pricing deviations, users can receive professional YES / NO trading recommendations in markets such as "BTC Price Range Prediction". Unlike traditional "predict up or down" strategies, the core of Prediction Copilot is not about predicting direction but about identifying mispricing in the market. The system combines multi-dimensional technical indicators such as RSI, MACD, EMA, SuperTrend, trading volume, and funding rates to provide real-time AI probability, market implied probability, edge, and expected returns, and supports real-time signal cards, one-click trade execution, probability comparison, and range market analysis functions. With this feature, users' prediction market trading models will upgrade from "emotional betting" to "AI-driven realization of mathematical probabilities".

Golden Ten Data reported on May 11 that JPMorgan has raised its target price for South Korean equities for the second time in less than a month, citing an improving semiconductor cycle, corporate governance reforms, and growth in the industrial sector. The Wall Street investment bank increased its base target for the KOSPI index to 9,000 points and its bullish scenario target to 10,000 points, suggesting there is still a 33% upside from last Friday‘s closing price. By comparison, the bank’s base and bullish targets set in late April were 7,000 and 8,500 points, respectively. Propelled by profit growth fueled by the global artificial intelligence (AI) boom, strategists are racing to raise their outlook for South Korean equities. On Monday, the KOSPI index soared as much as 5.1%, hitting a record intraday high of 7,876.60 points and extending its year-to-date gains to approximately 86%, further consolidating its position as one of the world’s best-performing stock markets. Last week, Goldman Sachs also raised its KOSPI index target to 9,000 points.